# Merkel-Cell Carcinoma: Local Recurrence Rate Versus Radiation Dose Study from a 949-Patient Database

**Authors:** Patricia Tai, Michael Veness, Vimal H. Prajapati, Aoife Jones Thachuthara, Jidong Lian, Avi Assouline, Edward Yu, Kurian Joseph

PMC · DOI: 10.3390/curroncol32040202 · 2025-03-28

## TL;DR

This study finds that higher radiation doses reduce local recurrence in Merkel-cell carcinoma patients.

## Contribution

The study uniquely stratifies recurrence rates by radiation dose and treatment settings in a large patient database.

## Key findings

- A local recurrence rate of 23% was observed in irradiated patients without chemotherapy.
- Radiation doses below 50 Gy2 showed significantly higher recurrence rates than doses of 50 Gy2 or more.
- The study highlights the need for prospective research to determine optimal radiotherapy doses.

## Abstract

(1) Background: Knowledge regarding the optimal radiotherapy dose for Merkel-cell carcinoma (MCC) remains limited. (2) Methods: Following a PubMed search, equivalent doses in 2 Gy fractions (Gy2) were compared. (3) Results: Of the 949 patients, 939 were evaluable, with 728 (77.5%) cases localized to the primary site and 171 irradiated without chemotherapy. The overall local recurrence rate (LRR) was 23% (40/171). After definitive radiotherapy with EQD2 < 50 Gy2 versus ≥50 Gy2, the LRRs were 23.1% (3/13) and 12.5% a(1/8), respectively (p = 0.0004). (4) Conclusions: For definitive radiotherapy, EQD2 < 50 Gy2 demonstrates a significantly higher LRR than ≥50 Gy2 (p = 0.0004). This study is clinically useful and unique with stratification by definitive/adjuvant settings and positive/negative resection margins. A future prospective multicenter study is needed to determine the optimal radiotherapy doses.

## Linked entities

- **Diseases:** Merkel-cell carcinoma (MONDO:0019210)

## Full-text entities

- **Diseases:** MCC (MESH:D015266)
- **Species:** Homo sapiens (human, species) [taxon 9606]

---
Source: https://tomesphere.com/paper/PMC12026359